Does ABIRATERONE Cause Supraventricular tachycardia? 11 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Supraventricular tachycardia have been filed in association with ABIRATERONE (Abiraterone Acetate). This represents 0.0% of all adverse event reports for ABIRATERONE.
11
Reports of Supraventricular tachycardia with ABIRATERONE
0.0%
of all ABIRATERONE reports
2
Deaths
8
Hospitalizations
How Dangerous Is Supraventricular tachycardia From ABIRATERONE?
Of the 11 reports, 2 (18.2%) resulted in death, 8 (72.7%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Supraventricular tachycardia Listed in the Official Label?
Yes, Supraventricular tachycardia is listed as a known adverse reaction in the official FDA drug label for ABIRATERONE.
What Other Side Effects Does ABIRATERONE Cause?
Death (5,623)
Fatigue (1,928)
Drug ineffective (1,732)
Therapy cessation (1,602)
Prostatic specific antigen increased (1,581)
Disease progression (1,098)
Hospitalisation (1,034)
Hot flush (989)
Asthenia (891)
Off label use (859)
What Other Drugs Cause Supraventricular tachycardia?
ADALIMUMAB (141)
METOPROLOL (132)
ROSIGLITAZONE (114)
TREPROSTINIL (113)
RITUXIMAB (99)
ALBUTEROL (98)
IBRUTINIB (96)
DEXAMETHASONE (95)
ASPIRIN (92)
LEVOTHYROXINE (91)
Which ABIRATERONE Alternatives Have Lower Supraventricular tachycardia Risk?
ABIRATERONE vs ABIRATERONE\ABIRATERONE
ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE vs ABRAXANE
ABIRATERONE vs ABROCITINIB
ABIRATERONE vs ACALABRUTINIB